An Observational Study of Hepatitis C Virus in Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

772 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multi-center observational study examines risk factors for HCV transmission from mother to baby.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

NCT06952036

HCV Infection HCV Elimination

NOT_YET_RECRUITING

Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers

NCT03038763

Hepatitis C Hepatitis C, Chronic

COMPLETED

Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants

NCT03539016

Hepatitis B, Chronic

UNKNOWN

Arresting Vertical Transmission of Hepatitis B Virus

NCT03567382

Hepatitis B Vertical Transmission of Infectious Disease

COMPLETED PHASE4

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

NCT00004850

Hepatitis C Hepatitis B

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multi-center observational study examines risk factors for HCV transmission from mother to baby. The study will also assess risk factors associated with Hepatitis C Virus (HCV) infection in pregnant women. Also, the study will describe the outcomes of pregnant women with HCV as well as the outcomes of their infants to 18 months of age.

Approximately 750 HCV antibody positive pregnant women and their infants will be followed from baseline until the infant is 18 months. A randomly selected control cohort of 500 pregnant women who are HCV antibody negative will be followed until delivery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis C

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Singleton pregnancy
2. An HCV antibody positive screen (case) measured using two FDA-approved ELISA tests, the Abbott Architect version 3.0 system and the Ortho HCV 3.0.
3. Gestational age at screening no later than 23 weeks and 6 days, and gestational age at enrollment no later than 27 weeks and 6 days, based on clinical information and evaluation of the earliest ultrasound as described below.

Exclusion Criteria

1. Planned termination of pregnancy
2. Known major fetal anomalies or demise
3. Intention of the patient or the managing obstetricians for the delivery to be outside a MFMU Network center, unless special provisions are made to insure infant follow-up at two and 18 months of age.
4. Participation in this study in a previous pregnancy.
5. Unwilling or unable to commit to 18 months of follow-up for HCV positive infants

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No